583 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·BETA-CATH(TM)SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·BETA-CATH(TM) SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·BETA-CATH(TM) SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA - CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·BETA-CATH(TM) SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE/BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE(TM) BETA-CATH SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH 3.5F SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH 3.5 SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH 3.5F SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH 3.5 SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE BETA-CATH 3.5F SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE(TM) BETA-CATH(TM) SYSTEM
Intravascular Radiation Delivery System
FDA Pre-Market Approval
FDA Class 3
·NOVOSTE TM BETA-CATH TM SYSTEM
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA Pre-Market Approval
FDA Class 3
·TRUFIL N-BCA LIQUID EMBOLIC SYSTEM